NF-κB signaling, liver disease and hepatoprotective agents
Open Access
- 20 October 2008
- journal article
- review article
- Published by Springer Science and Business Media LLC in Oncogene
- Vol. 27 (48), 6228-6244
- https://doi.org/10.1038/onc.2008.300
Abstract
The NF-κB signaling pathway has particular relevance to several liver diseases including hepatitis (liver infection by Helicobacter, viral hepatitis induced by HBV and HCV), liver fibrosis and cirrhosis and hepatocellular carcinoma. Furthermore, the NF-κB signaling pathway is a potential target for development of hepatoprotective agents. Several types of drugs including: selective estrogen receptor modulators (SERMs), antioxidants, proteasome inhibitors, IKK inhibitors and nucleic acid-based decoys have been shown to interfere with NF-κB activity at different levels and may be useful for the treatment of liver diseases. However, NF-κB also plays an important hepatoprotective function that needs to be taken into consideration during development of new therapeutic regimens.Keywords
This publication has 165 references indexed in Scilit:
- Hepatocyte Necrosis Induced by Oxidative Stress and IL-1α Release Mediate Carcinogen-Induced Compensatory Proliferation and Liver TumorigenesisCancer Cell, 2008
- NF-κB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1αNature, 2008
- Adherence, Internalization, and Persistence of Helicobacter pylori in HepatocytesDigestive Diseases and Sciences, 2008
- RNAi for Treating Hepatitis B Viral InfectionPharmaceutical Research, 2007
- NF-κB Is a Negative Regulator of IL-1β Secretion as Revealed by Genetic and Pharmacological Inhibition of IKKβCell, 2007
- Antiviral and immunoregulatory activities of IFN-γ depend on constitutively expressed IL-1αProceedings of the National Academy of Sciences of the United States of America, 2007
- Unravelling the complexities of the NF-κB signalling pathway using mouse knockout and transgenic modelsOncogene, 2006
- Loss of hepatic NF-κB activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activationProceedings of the National Academy of Sciences, 2006
- Nuclear factor-κB in cancer development and progressionNature, 2006
- Helicobacter pyloriInfection and the Development of Gastric CancerNew England Journal of Medicine, 2001